Abigail K. R. Lytton‐Jean

Publications

10.1K

Citations

H-Index

2003

Active since

Affiliations

Massachusetts Institute of Technology(Current)

Harvard University

Northwestern University

Harvard–MIT Division of Health Sciences and Technology

Alnylam Pharmaceuticals (United States)

Abigail K. R. Lytton‐Jean is an author at Massachusetts Institute of Technology specializing in engineering, nanomedicine, and biomedical engineering.

ORCID

Top concepts

EngineeringNanomedicineBiomedical EngineeringNanoparticlesMolecular BiologyMedicineBiophysicsNatural SciencesSelf-assemblyNanotechnology

Publications per year

2003–2024

Publications

Oligonucleotide-Modified Gold Nanoparticles for Intracellular Gene Regulation

Nathaniel L. Rosi, David A. Giljohann, C. Shad Thaxton et al. · Science · 2006 · 2K citations

Nanoparticles, Engineering, Metal Nanoparticles +16

DNA-programmable nanoparticle crystallization

Abigail K. R. Lytton‐Jean, Byeongdu Lee, Steven Weigand et al. · Nature · 2008 · 1.5K citations

Nanoparticles, Dna Nanotechnology, Engineering +4

Maximizing DNA Loading on a Range of Gold Nanoparticle Sizes

Sarah J. Hurst, Abigail K. R. Lytton‐Jean, Chad A. Mirkin · Analytical Chemistry · 2006 · 1.2K citations · Full text

Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery

Hyukjin Lee, Abigail K. R. Lytton‐Jean, Yi Chen et al. · Nature Nanotechnology · 2012 · 1.2K citations · Full text

Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy

Daniel Shae, Kyle W. Becker, Plamen P. Christov et al. · Nature Nanotechnology · 2019 · 633 citations

Polymer-drug Conjugate, Cyclic Dinucleotide Sting, Immunology +7

Rows per page

1–5 of 31